Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
Journal of Biopharmaceutical Statistics|January 25, 2022
A stochastically curtailed single-arm phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pharmaceutical Statistics|August 30, 2020
A stochastically curtailed two-arm randomised phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pharmaceutical Statistics|November 27, 2015
Do single-arm trials have a role in drug development plans incorporating randomised trials?Michael J Grayling, Adrian P Mander
JCO Precision Oncology|December 24, 2021
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported AdequatelyMichael J Grayling, Adrian P Mander
Journal of Biopharmaceutical Statistics|February 23, 2022
Optimised point estimators for multi-stage single-arm phase II oncology trialsMichael J Grayling, Adrian P Mander
Contemporary Clinical Trials|June 3, 2021
Accounting for variation in the required sample size in the design of group-sequential trialsMichael J Grayling, Adrian P Mander
BMC Medical Research Methodology|January 30, 2019
Re-formulating Gehan's design as a flexible two-stage single-arm trialMichael J Grayling, Adrian P Mander
Trials|December 4, 2019
Sample size re-estimation in crossover trials: application to the AIM HY-INFORM studyJulie Wych, Michael J Grayling, Adrian P Mander
Clinical Trials (London, England)|June 28, 2017
Group sequential designs for stepped-wedge cluster randomised trialsMichael J Grayling, James Ms Wason, Adrian P Mander
Pageof 14